1Candinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study(4S) [J].Lancet, 1994,344:1383-1389.
2Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals:a randomized placebo-controlled trial [J], Lancet, 2002,360: 7-22.
3Cannon C, Braunwald E, McCabe C, et al. Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes (PROVE IT-TIMI 22) [J]. New Engl J Med, 2004,350: 1495-1504
4Grundy SM, Cleeman JI, Bairey NM, et al. Implication of recent clinical trials for the national cholesterol education program adult treatment panel Ⅲ guidelines [J]. Circulation,2004,110:227-239
5Pedersen TR, Faergeman O, Kastelein JJ, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial [J]. JAMA, 2005,294(19):2437-2445.
6Lipka LJ. Ezetimibe : a first-in-class, novel cholesterol absorption inhibitor [J]. Cardiovasc Drug Rev, 2003,21:293-312.
7Pitt B. Low-density lipoprotein cholesterol in patients with stable coronary heart disease-is it time to shift our goals?[J]. N Engl J Med, 2005,352(14):1483-1484.
